Mode
Text Size
Log in / Sign up
N/A Completed N=12 Supportive Care

Low-Level Laser in Treatment of Head and Neck Lymphedema: A Pilot Study

Source: ClinicalTrials.gov NCT03738332 ↗
Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Jan 2022
Primary outcomePrimary: Number of Participants Consented and Enrolled in Study — 12 Participants

Summary

The purpose of this pilot clinical trial is to evaluate the feasibility of the use of low-level laser for head and neck cancer survivors with lymphedema.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Consented and Enrolled in Study
12 —
PRIMARY
Number of Participants Completed the Study Visits
11 —
PRIMARY
Number of Participants With Adverse Events
— —
PRIMARY
Number of Participants Who Were Satisfied With Study Intervention.
11 —

Eligibility Criteria

Inclusion Criteria

  • >18 years of age
  • Completion of either postoperative radiation or chemoradiation therapy
  • No evidence of cancer
  • Having head and neck external lymphedema
  • Either completion of lymphedema therapy or not in active lymphedema therapy
  • Ability to speak and read English
  • Able to provide informed consent

Exclusion Criteria

Patients will be excluded if they have any of the following medical conditions that would prohibit the safe implementation of LLLT: pregnancy; photosensitivity; chronic inflammatory diseases; venous thrombosis; history of severe trauma; medication that affects body fluid and electrolyte balance; use of high doses of non-steroidal anti-inflammatory drugs; or pre-existing skin rash, ulceration, open wound in the treatment area; and allergic and other systemic skin diseases.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03738332). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search